Logo image of ALAVI.PA

ADVINI (ALAVI.PA) Stock Fundamental Analysis

Europe - EPA:ALAVI - FR0000053043 - Common Stock

13 EUR
+1 (+8.33%)
Last: 10/10/2025, 7:00:00 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to ALAVI. ALAVI was compared to 29 industry peers in the Beverages industry. ALAVI has a bad profitability rating. Also its financial health evaluation is rather negative. ALAVI has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

ALAVI had positive earnings in the past year.
In the past year ALAVI had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: ALAVI reported negative net income in multiple years.
In the past 5 years ALAVI always reported a positive cash flow from operatings.
ALAVI.PA Yearly Net Income VS EBIT VS OCF VS FCFALAVI.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M 40M

1.2 Ratios

The Return On Assets of ALAVI (0.07%) is worse than 86.21% of its industry peers.
Looking at the Return On Equity, with a value of 0.34%, ALAVI is doing worse than 86.21% of the companies in the same industry.
ALAVI has a Return On Invested Capital of 3.52%. This is amonst the worse of the industry: ALAVI underperforms 82.76% of its industry peers.
Industry RankSector Rank
ROA 0.07%
ROE 0.34%
ROIC 3.52%
ROA(3y)-0.96%
ROA(5y)-0.58%
ROE(3y)-5.25%
ROE(5y)-3.24%
ROIC(3y)N/A
ROIC(5y)N/A
ALAVI.PA Yearly ROA, ROE, ROICALAVI.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

With a Profit Margin value of 0.09%, ALAVI is not doing good in the industry: 86.21% of the companies in the same industry are doing better.
ALAVI's Profit Margin has declined in the last couple of years.
ALAVI has a Operating Margin of 3.23%. This is amonst the worse of the industry: ALAVI underperforms 89.66% of its industry peers.
ALAVI's Operating Margin has improved in the last couple of years.
ALAVI has a Gross Margin of 36.00%. This is amonst the worse of the industry: ALAVI underperforms 82.76% of its industry peers.
ALAVI's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 3.23%
PM (TTM) 0.09%
GM 36%
OM growth 3Y3.73%
OM growth 5Y6.09%
PM growth 3Y-60.56%
PM growth 5Y-41.13%
GM growth 3Y14.56%
GM growth 5Y8.11%
ALAVI.PA Yearly Profit, Operating, Gross MarginsALAVI.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ALAVI is destroying value.
Compared to 1 year ago, ALAVI has less shares outstanding
ALAVI has less shares outstanding than it did 5 years ago.
The debt/assets ratio for ALAVI has been reduced compared to a year ago.
ALAVI.PA Yearly Shares OutstandingALAVI.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M
ALAVI.PA Yearly Total Debt VS Total AssetsALAVI.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

Based on the Altman-Z score of 0.70, we must say that ALAVI is in the distress zone and has some risk of bankruptcy.
ALAVI has a worse Altman-Z score (0.70) than 96.55% of its industry peers.
ALAVI has a debt to FCF ratio of 7.28. This is a slightly negative value and a sign of low solvency as ALAVI would need 7.28 years to pay back of all of its debts.
ALAVI has a Debt to FCF ratio (7.28) which is in line with its industry peers.
A Debt/Equity ratio of 1.41 is on the high side and indicates that ALAVI has dependencies on debt financing.
ALAVI has a Debt to Equity ratio of 1.41. This is in the lower half of the industry: ALAVI underperforms 72.41% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.41
Debt/FCF 7.28
Altman-Z 0.7
ROIC/WACC0.67
WACC5.23%
ALAVI.PA Yearly LT Debt VS Equity VS FCFALAVI.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

ALAVI has a Current Ratio of 0.64. This is a bad value and indicates that ALAVI is not financially healthy enough and could expect problems in meeting its short term obligations.
ALAVI's Current ratio of 0.64 is on the low side compared to the rest of the industry. ALAVI is outperformed by 96.55% of its industry peers.
ALAVI has a Quick Ratio of 0.64. This is a bad value and indicates that ALAVI is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of ALAVI (0.21) is worse than 89.66% of its industry peers.
Industry RankSector Rank
Current Ratio 0.64
Quick Ratio 0.21
ALAVI.PA Yearly Current Assets VS Current LiabilitesALAVI.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

5

3. Growth

3.1 Past

ALAVI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 101.76%, which is quite impressive.
Measured over the past years, ALAVI shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -40.47% on average per year.
The Revenue has decreased by -3.23% in the past year.
Measured over the past years, ALAVI shows a small growth in Revenue. The Revenue has been growing by 0.81% on average per year.
EPS 1Y (TTM)101.76%
EPS 3Y-60.2%
EPS 5Y-40.47%
EPS Q2Q%127.97%
Revenue 1Y (TTM)-3.23%
Revenue growth 3Y-0.32%
Revenue growth 5Y0.81%
Sales Q2Q%-4.45%

3.2 Future

Based on estimates for the next years, ALAVI will show a very strong growth in Earnings Per Share. The EPS will grow by 84.55% on average per year.
ALAVI is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.75% yearly.
EPS Next Y126.09%
EPS Next 2Y84.55%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year1.94%
Revenue Next 2Y2.75%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ALAVI.PA Yearly Revenue VS EstimatesALAVI.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M
ALAVI.PA Yearly EPS VS EstimatesALAVI.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.5 -0.5 1 1.5

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 185.71, which means the current valuation is very expensive for ALAVI.
Based on the Price/Earnings ratio, ALAVI is valued more expensive than 86.21% of the companies in the same industry.
ALAVI is valuated expensively when we compare the Price/Earnings ratio to 27.02, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 70.12 indicates a quite expensive valuation of ALAVI.
82.76% of the companies in the same industry are cheaper than ALAVI, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of ALAVI to the average of the S&P500 Index (22.57), we can say ALAVI is valued expensively.
Industry RankSector Rank
PE 185.71
Fwd PE 70.12
ALAVI.PA Price Earnings VS Forward Price EarningsALAVI.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ALAVI is valued cheaper than 86.21% of the companies in the same industry.
100.00% of the companies in the same industry are more expensive than ALAVI, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 1.95
EV/EBITDA 6.31
ALAVI.PA Per share dataALAVI.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

ALAVI's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as ALAVI's earnings are expected to grow with 84.55% in the coming years.
PEG (NY)1.47
PEG (5Y)N/A
EPS Next 2Y84.55%
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

ALAVI has a Yearly Dividend Yield of 2.08%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.83, ALAVI is paying slightly less dividend.
Compared to an average S&P500 Dividend Yield of 2.44, ALAVI has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.08%

5.2 History

The dividend of ALAVI is nicely growing with an annual growth rate of 13.49%!
Dividend Growth(5Y)13.49%
Div Incr Years0
Div Non Decr Years0
ALAVI.PA Yearly Dividends per shareALAVI.PA Yearly Dividends per shareYearly Dividends per share 2023 0.1 0.2 0.3

5.3 Sustainability

The dividend of ALAVI is growing, but earnings are growing more, so the dividend growth is sustainable.
DP0%
EPS Next 2Y84.55%
EPS Next 3YN/A
ALAVI.PA Yearly Income VS Free CF VS DividendALAVI.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

ADVINI

EPA:ALAVI (10/10/2025, 7:00:00 PM)

13

+1 (+8.33%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)10-08 2025-10-08
Earnings (Next)02-11 2026-02-11
Inst Owners0.3%
Inst Owner ChangeN/A
Ins Owners23.43%
Ins Owner ChangeN/A
Market Cap51.22M
Analysts84.44
Price Target12.24 (-5.85%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.08%
Yearly Dividend0.35
Dividend Growth(5Y)13.49%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 185.71
Fwd PE 70.12
P/S 0.18
P/FCF 1.95
P/OCF 1.63
P/B 0.72
P/tB 1.66
EV/EBITDA 6.31
EPS(TTM)0.07
EY0.54%
EPS(NY)0.19
Fwd EY1.43%
FCF(TTM)6.67
FCFY51.27%
OCF(TTM)7.97
OCFY61.3%
SpS70.44
BVpS18.06
TBVpS7.83
PEG (NY)1.47
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.07%
ROE 0.34%
ROCE 8.68%
ROIC 3.52%
ROICexc 3.84%
ROICexgc 5.03%
OM 3.23%
PM (TTM) 0.09%
GM 36%
FCFM 9.46%
ROA(3y)-0.96%
ROA(5y)-0.58%
ROE(3y)-5.25%
ROE(5y)-3.24%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y23.09%
ROICexcg growth 5Y20.02%
ROICexc growth 3Y19.05%
ROICexc growth 5Y17.2%
OM growth 3Y3.73%
OM growth 5Y6.09%
PM growth 3Y-60.56%
PM growth 5Y-41.13%
GM growth 3Y14.56%
GM growth 5Y8.11%
F-Score8
Asset Turnover0.75
Health
Industry RankSector Rank
Debt/Equity 1.41
Debt/FCF 7.28
Debt/EBITDA 4.44
Cap/Depr 37.64%
Cap/Sales 1.85%
Interest Coverage 0.89
Cash Conversion 138.91%
Profit Quality 10807.4%
Current Ratio 0.64
Quick Ratio 0.21
Altman-Z 0.7
F-Score8
WACC5.23%
ROIC/WACC0.67
Cap/Depr(3y)63.63%
Cap/Depr(5y)65.26%
Cap/Sales(3y)2.99%
Cap/Sales(5y)3.17%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)101.76%
EPS 3Y-60.2%
EPS 5Y-40.47%
EPS Q2Q%127.97%
EPS Next Y126.09%
EPS Next 2Y84.55%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-3.23%
Revenue growth 3Y-0.32%
Revenue growth 5Y0.81%
Sales Q2Q%-4.45%
Revenue Next Year1.94%
Revenue Next 2Y2.75%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y252.48%
EBIT growth 3Y3.4%
EBIT growth 5Y6.95%
EBIT Next Year166.2%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y383.67%
FCF growth 3Y13.52%
FCF growth 5Y-5.11%
OCF growth 1Y7849.37%
OCF growth 3Y4.32%
OCF growth 5Y-6.75%